{"schema_version":"secwatch.filing_event.v1","accession":"0001402479-23-000064","form_type":"8-K","ticker":null,"cik":"0001402479","company_name":"MedAvail Holdings, Inc.","filed_at":"2023-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.715082+00:00","generated_at":"2026-06-13T22:27:29.311437+00:00","sec_items":["4.01","5.07","8.01"],"event_type":"other","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MedAvail shareholders approve reverse split 1:30-1:80; issue warrants for 49.8M shares","bullets":["Reverse split approved with 70.4M votes for, 1.35M against; ratio range 1:30 to 1:80, board to set final ratio.","Series A warrants for up to 49.8M shares at $0.38544/share issued to 4 institutional investors, 5-year term.","Auditor changed: Baker Tilly resigned May 18; SingerLewak engaged as independent public accounting firm effective June 14.","Class III directors elected: Faulkner, Stettin, Kramer; each received majority votes at annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001402479-23-000064","json":"https://secwatch.observer/filing/0001402479-23-000064.json","markdown":"https://secwatch.observer/filing/0001402479-23-000064.md","text":"https://secwatch.observer/filing/0001402479-23-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000064/0001402479-23-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000064/medavail-20230614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T22:27:29.311437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5bf5eff5870f0bbc5f9522f5f9c41f4414fa3e37","claim":"MedAvail Holdings, Inc. engaged SingerLewak LLP as its auditor.","evidence_excerpt":"On June 14, 2023, MedAvail Holdings, Inc. engaged SingerLewak LLP as our independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000064/0001402479-23-000064-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"SingerLewak LLP"}],"fact_type":"auditor_change"},{"claim_id":"642a52b3a59d829d83c2b6b52ee97598dafe1ef6","claim":"MedAvail Holdings, Inc. shareholders approved Election of three Class III directors to serve until the 2026 annual meeting at the 2023-06-14 meeting.","evidence_excerpt":"The stockholders elected each of the three persons named below as Class III directors to serve until the 2026 annual meeting of stockholders or until their successors are duly elected and qualified.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000064/0001402479-23-000064-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"b796dac79aa3dad19bdd249ae851b7732c580333","claim":"MedAvail Holdings, Inc. shareholders approved Approval of an amendment of our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio in the range of not less than 1-for-30 and no greater than 1-for-80 at the 2023-06-14 meeting.","evidence_excerpt":"The stockholders approved an amendment of our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio in the range of not less than 1-for-30 and no greater than 1-for-80, with such ratio to be determined in the discretion of our board of directors or a duly authorized committee thereof.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000064/0001402479-23-000064-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"d3a1cdec832cd8843cd0104647632e0d4e9e4a58","claim":"MedAvail Holdings, Inc. shareholders approved Approval of the issuance of 20% or more of the outstanding shares of our common stock at a price less than the Minimum Price as defined by and in accordance with Nasdaq Listing Rule 5635(d) upon the exercise of certain pre-funded warrants and series A warrants at the 2023-06-14 meeting.","evidence_excerpt":"The stockholders approved the issuance of 20% or more of the outstanding shares of our common stock at a price less than the Minimum Price as defined by and in accordance with Nasdaq Listing Rule 5635(d) upon the exercise of certain pre-funded warrants and series A warrants issued in a private placement of our securities.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000064/0001402479-23-000064-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}